| Literature DB >> 29061507 |
Xiu-Tao Fu1, Ying-Hong Shi2, Jian Zhou3, Yuan-Fei Peng4, Wei-Ren Liu5, Guo-Ming Shi6, Qiang Gao7, Xiao-Ying Wang8, Kang Song9, Jia Fan10, Zhen-Bin Ding11.
Abstract
MiRNA-30a (miR-30a) was previously reported as one of metastatic hepatocellular carcinoma (HCC)-related microRNAs. However, the function of miR-30a on enhancing our biological understanding of HCC metastasis is not clear. This study demonstrated that miR-30a was significantly down-regulated in HCC tissues and cell lines, and was associated with vascular invasion, metastasis potential and recurrent disease in HCC. Functional studies confirmed that miR-30a could inhibit the metastasis of HCC in a well-established nude mouse model of lung metastasis. Moreover, miR-30a was proved to prevent anoikis inhibition of HCC cells in vivo and in vitro. Mechanically, autophagy related protein Beclin 1 and Atg5 were direct downstream targets of miR-30a, and mediated autophagy activity influence of miR-30a in HCC. Taken together, downregulated miR-30a in metastatic HCC mediates Beclin 1 and Atg5-dependent autophagy, which confers anoikis resistance in HCC cells. The molecular basis of autophagy action during this process partly contributes to the HCC metastasis, suggesting that targeting autophagy via miR-30a may have therapeutic implications for the prevention of HCC recurrence/metastasis.Entities:
Keywords: Anoikis; Autophagy; Hepatocellular carcinoma; Metastasis; MiroRNA-30a
Mesh:
Substances:
Year: 2017 PMID: 29061507 DOI: 10.1016/j.canlet.2017.10.012
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679